|Broad consent for research with biological samples: workshop conclusions|
C Grady, L Eckstein, B Berkman, D Brock, R Cook-Deegan, SM Fullerton, ...
The American Journal of Bioethics 15 (9), 34-42, 2015
|A framework for analyzing the ethics of disclosing genetic research findings|
L Eckstein, JR Garrett, BE Berkman
Journal of Law, Medicine & Ethics 42 (2), 190-207, 2014
|The unintended implications of blurring the line between research and clinical care in a genomic age|
BE Berkman, SC Hull, L Eckstein
Personalized Medicine 11 (3), 285-295, 2014
|Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic|
D Nicol, L Eckstein, M Morrison, JS Sherkow, M Otlowski, T Whitton, ...
Genome medicine 9 (1), 1-4, 2017
|Toward better governance of human genomic data|
KC O’Doherty, M Shabani, ES Dove, HB Bentzen, P Borry, MM Burgess, ...
Nature genetics 53 (1), 2-8, 2021
|Australia: regulating genomic data sharing to promote public trust|
L Eckstein, D Chalmers, C Critchley, R Jeanneret, R McWhirter, J Nielsen, ...
Human Genetics 137 (8), 583-591, 2018
|Moving forward on consent practices in Australia|
RE McWhirter, L Eckstein
Journal of Bioethical Inquiry 15 (2), 243-257, 2018
|Building a more connected DSMB: better integrating ethics review and safety monitoring|
Accountability in research 22 (2), 81-105, 2015
|Consent insufficient for data release|
D Nicol, L Eckstein, HB Bentzen, P Borry, M Burgess, W Burke, ...
Science 364 (6439), 445-446, 2019
|The ethics of large-scale genomic research|
BE Berkman, ZE Shapiro, L Eckstein, ER Pike
Ethical Reasoning in Big Data, 53-69, 2016
|Beyond racial and ethnic analyses in clinical research: a proposed model for Institutional Review Boards|
Food & Drug LJ 66, 243, 2011
|Engaging racial and ethnic groups in the regulation of research: lessons from research in emergency settings|
Hous. J. Health L. & Pol'y 12, 1, 2011
|Assessing the legal duty to use or disclose interim data for ongoing clinical trials|
Journal of Law and the Biosciences 6 (1), 51-84, 2019
|Gene Editing Clinical Trials Could Slip through Australian Regulatory Cracks.|
D Nicol, L Eckstein
Journal of law and Medicine 27 (2), 274-283, 2019
|Enhancing early detection of cognitive impairment in the criminal justice system: feasibility of a proposed method|
R Jeanneret, C Spiranovic, L Eckstein, R McWhirter, A Arstein-Kerslake, ...
Current Issues in Criminal Justice 31 (1), 60-74, 2019
|Strategies to guide the return of genomic research findings: an Australian perspective|
L Eckstein, M Otlowski
Journal of Bioethical Inquiry 15 (3), 403-415, 2018
|Criteria for Decision-Making Capacity: Between Understanding and Evidencing a Choice.|
Journal of law and Medicine 24 (3), 678-694, 2017
|Integrating public participation, transparency and accountability into governance of marketing authorisation for genome editing products|
J Nielsen, L Eckstein, D Nicol, C Stewart
Frontiers in Political Science 3, 1-13, 2021
|Regulatory Challenges of Synthetic Biology Trials and Other Highly Innovation Investigational Products|
Macquarie LJ 15, 65, 2015
|Australian human research ethics committee members’ confidence in reviewing genomic research applications|
R Pysar, CK Wallingford, J Boyle, SB Campbell, L Eckstein, R McWhirter, ...
European Journal of Human Genetics 29 (12), 1811-1818, 2021